Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease?

Current Pharmaceutical Design

Volumn 18, Issue 15, 2012, Pages 2223-2235

  Meairs, Stephen ^a   Kern, Rolf ^a   Alonso, Angelika ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Microbubbles; Perfusion; Sonothrombolysis; Stroke; Therapy; Ultrasound

Indexed keywords

PERFLUTREN; SHU 508; SONOVUE;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BASILAR ARTERY; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; DRUG DELIVERY SYSTEM; HUMAN; INFLAMMATION; INTRACRANIAL ANEURYSM; KINETICS; MICROBUBBLE; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; PATHOPHYSIOLOGY; PATIENT SAFETY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; THROMBOGENESIS; UNSPECIFIED SIDE EFFECT; VERTEBRAL ARTERY;

ANIMALS; BLOOD-BRAIN BARRIER; CAROTID STENOSIS; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC; THROMBOLYTIC THERAPY;

EID: 84860150026     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212800099982     Document Type: Article

References (149)

1. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989; 15: 319-333.
2. Burns PN. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology. J Neuroimaging 1997; 7 Suppl 1: S2-S14.
3. Reale A, Pizzuto F, Gioffre PA, et al. Contrast echocardiography: transmission of echoes to the left heart across the pulmonary vascular bed. Eur Heart J 1980; 1: 101-106.
4. Van Liew HD, Raychaudhuri S. Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization. J Appl Physiol 1997; 82: 2045-2053.
5. Kabalnov A, Bradley J, Flaim S, et al. Dissolution of multicomponent microbubbles in the bloodstream: 2. Experiment. Ultrasound Med Biol 1998; 24: 751-760.
6. Chang PH, Shung KK, Levene HB. Quantitative measurements of second harmonic Doppler using ultrasound contrast agents. Ultrasound Med Biol 1996; 22: 1205-1214.
7. Ries F, Honisch C, Lambertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke 1993; 24: 1903-1909.
8. Otis S, Rush M, Boyajian R. Contrast-enhanced transcranial imaging. Results of an American phase- two study. Stroke 1995; 26: 203-209.
9. Gerriets T, Seidel G, Fiss I, Modrau B, Kaps M. Contrast-enhanced transcranial color-coded duplex sonography: efficiency and validity. Neurology 1999; 52: 1133-1137.
10. Murphy KJ, Bude RO, Dickinson LD, Rubin JM. Use of intravenous contrast material in transcranial sonography. Acad Radiol 1997; 4: 577-582.
11. Baumgartner RW, Arnold M, Gonner F, et al. Contrast-enhanced transcranial color-coded duplex sonography in ischemic cerebrovascular disease. Stroke 1997; 28: 2473-2448.
12. Nabavi DG, Droste DW, Kemeny V, Schulte-Altedorneburg G, Weber S, Ringelstein EB. Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: a pilot study. Stroke 1998; 29: 949-954.
13. Nabavi DG, Droste DW, Schulte-Altedorneburg G, et al. Diagnostic benefit of echocontrast enhancement for the insufficient transtemporal bone window. J Neuroimaging 1999; 9: 102-107.
14. Iglseder B, Huemer M, Staffen W, Ladurner G. Imaging the basilar artery by contrast-enhanced color-coded ultrasound. J Neuroimaging 2000; 10: 195-199.
15. Droste DW, Nabavi DG, Kemeny V, et al. Echocontrast enhanced transcranial colour-coded duplex offers improved visualization of the vertebrobasilar system. Acta Neurol Scand 1998; 98: 193-199.
16. Koga M, Kimura K, Minematsu K, Yamaguchi T. Relationship between findings of conventional and contrast-enhanced transcranial color-coded real-time sonography and angiography in patients with basilar artery occlusion. AJNR Am J Neuroradiol 2002; 23: 568-571.
17. Griewing B, Motsch L, Piek J, Schminke U, Brassel F, Kessler C. Transcranial power mode Doppler duplex sonography of intracranial aneurysms. J Neuroimaging 1998; 8: 155-158.
18. Uggowitzer MM, Kugler C, Riccabona M, et al. Cerebral arteriovenous malformations: diagnostic value of echo-enhanced transcranial Doppler sonography compared with angiography. Am J Neuroradiol 1999; 20: 101-106.
19. Strandness DE, Eikelboom BC. Carotid artery stenosis--where do we go from here? Eur J Ultrasound 1998; 7 Suppl 3: S17-S26.
20. Sitzer M, Furst G, Siebler M, Steinmetz H. Usefulness of an intravenous contrast medium in the characterization of high-grade internal carotid stenosis with color Doppler-assisted duplex imaging. Stroke 1994; 25: 385-389.
21. Sitzer M, Rose G, Furst G, Siebler M, Steinmetz H. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis. J Neuroimaging 1997; 7 Suppl 1: S22-S25.
22. Paterson JC. Capillary rupture with intimal haemorrhage as the causative factor in coronary thrombosis. Arch.Pathol. 474-487. 1938.
23. Geiringer E. Intimal vascularisation and atherosclerosis. Histologic characteristics of carotid atherosclerotid plaque. J.Pathol.Bacteriol. 201-211. 1951.
24. Feinstein SB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 2006; 48: 236-243.
25. Vicenzini E, Giannoni MF, Puccinelli F, et al. Detection of carotid adventitial vasa vasorum and plaque vascularization with ultrasound cadence contrast pulse sequencing technique and echo-contrast agent. Stroke 2007; 38: 2841-2843.
26. Shah F, Balan P, Weinberg M, et al. Contrast-enhanced ultrasound imaging of atherosclerotic carotid plaque neovascularization: a new surrogate marker of atherosclerosis? Vasc Med 2007; 12: 291-297.
27. Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr Mol Med 2006; 6: 549-556.
28. Huang PT, Huang FG, Zou CP, et al. Contrast-enhanced sonographic characteristics of neovascularization in carotid atherosclerotic plaques. J Clin Ultrasound 2008; 36: 346-351.
29. Giannoni MF, Vicenzini E, Citone M, et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009; 37: 722-727.
30. Krishnan S, O'Donnell M. Transmit aperture processing for nonlinear contrast agent imaging. Ultrason Imaging 1996; 18: 77-105.
31. Meairs S, Daffertshofer M, Neff W, Eschenfelder C, Hennerici M. Pulse-inversion contrast harmonic imaging: ultrasonographic assessment of cerebral perfusion. Lancet 2000; 355: 550-551.
32. Seidel G, Greis C, Sonne J, Kaps M. Harmonic grey scale imaging of the human brain. J Neuroimaging 1999; 9: 171-174.
33. Postert T, Muhs A, Meves S, Federlein J, Przuntek H, Buttner T. Transient response harmonic imaging: an ultrasound technique related to brain perfusion. Stroke 1998; 29: 1901-1907.
34. Eyding J, Krogias C, Wilkening W, Meves S, Ermert H, Postert T. Parameters of cerebral perfusion in phase-inversion harmonic imaging (PIHI) ultrasound examinations. Ultrasound Med Biol 2003; 29: 1379-1385.
35. Eyding J, Wilkening W, Reckhardt M, et al. Contrast burst depletion imaging (CODIM): a new imaging procedure and analysis method for semiquantitative ultrasonic perfusion imaging. Stroke 2003; 34: 77-83.
36. Eyding J, Wilkening W, Krogias C, et al. Validation of the depletion kinetic in semiquantitative ultrasonographic cerebral perfusion imaging using 2 different techniques of data acquisition. J Ultrasound Med 2004; 23: 1035-1040.
37. Harrer JU, Klotzsch C. Second harmonic imaging of the human brain: the practicability of coronal insonation planes and alternative perfusion parameters. Stroke 2002; 33: 1530-1535.
38. Krogias C, Postert T, Meves S, Wilkening W, Przuntek H, Eyding J. Semiquantitative analysis of ultrasonic cerebral perfusion imaging. Ultrasound Med Biol 2005; 31: 1007-1012.
39. Meves SH, Wilkening W, Thies T, et al. Comparison between echo contrast agent-specific imaging modes and perfusion-weighted magnetic resonance imaging for the assessment of brain perfusion. Stroke 2002; 33: 2433-2437.
40. Meyer K, Seidel G. Transcranial contrast diminution imaging of the human brain: a pilot study in healthy volunteers. Ultrasound Med Biol 2002; 28: 1433-1437.
41. Pohl C, Tiemann K, Schlosser T, Becher H. Stimulated acoustic emission detected by transcranial color doppler ultrasound: a contrast-specific phenomenon useful for the detection of cerebral tissue perfusion. Stroke 2000; 31: 1661-1666.
42. Postert T, Hoppe P, Federlein J, et al. Contrast agent specific imaging modes for the ultrasonic assessment of parenchymal cerebral echo contrast enhancement. J Cereb Blood Flow Metab 2000; 20: 1709-1716.
43. Seidel G, Algermissen C, Christoph A, Katzer T, Kaps M. Visualization of brain perfusion with harmonic gray scale and power doppler technology: an animal pilot study. Stroke 2000; 31: 1728-1734.
44. Seidel G, Meyer K, Metzler V, Toth D, Vida-Langwasser M, Aach T. Human cerebral perfusion analysis with ultrasound contrast agent constant infusion: a pilot study on healthy volunteers. Ultrasound Med Biol 2002; 28: 183-189.
45. Wiesmann M, Seidel G. Ultrasound perfusion imaging of the human brain. Stroke 2000; 31: 2421-2425.
46. Kern R, Perren F, Kreisel S, Szabo K, Hennerici M, Meairs S. Multi-planar transcranial ultrasound imaging - standards, landmarks and correlation with magnetic resonance imaging. Ultrasound Med Biol 2005; 31: 311-315.
47. Wiesmann M, Meyer K, Albers T, Seidel G. Parametric perfusion imaging with contrast-enhanced ultrasound in acute ischemic stroke. Stroke 2004; 35: 508-513.
48. Federlein J, Postert T, Meves S, Weber S, Przuntek H, Buttner T. Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging. J Neurol Neurosurg Psychiatry 2000; 69: 616-622.
49. Eyding J, Krogias C, Schollhammer M, et al. Contrast-enhanced ultrasonic parametric perfusion imaging detects dysfunctional tissue at risk in acute MCA stroke. J Cereb Blood Flow Metab 2006; 26: 576-582.
50. Eyding J, Nolte-Martin A, Krogias C, Postert T. Changes of contrast-specific ultrasonic cerebral perfusion patterns in the course of stroke; reliability of region-wise and parametric imaging analysis. Ultrasound Med Biol 2007; 33: 329-334.
51. Holscher T, Wilkening W, Draganski B, et al. Transcranial ultrasound brain perfusion assessment with a contrast agent-specific imaging mode: results of a two-center trial. Stroke 2005; 36: 2283-2285.
52. Seidel G, Meyer-Wiethe K, Berdien G, Hollstein D, Toth D, Aach T. Ultrasound perfusion imaging in acute middle cerebral artery infarction predicts outcome. Stroke 2004; 35: 1107-1111.
53. Sobesky J, Zaro WO, Lehnhardt FG, et al. Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke. Stroke 2004; 35: 2843-2847.
54. Kern R, Perren F, Schoeneberger K, Gass A, Hennerici M, Meairs S. Ultrasound microbubble destruction imaging in acute middle cerebral artery stroke. Stroke 2004; 35: 1665-1670.
55. Meyer-Wiethe K, Cangur H, Seidel GU. Comparison of different mathematical models to analyze diminution kinetics of ultrasound contrast enhancement in a flow phantom. Ultrasound Med Biol 2005; 31: 93-98.
56. Lucidarme O, Kono Y, Corbeil J, Choi SH, Mattrey RF. Validation of ultrasound contrast destruction imaging for flow quantification. Ultrasound Med Biol 2003; 29: 1697-1704.
57. Meairs S. Contrast-enhanced ultrasound perfusion imaging in acute stroke patients. Eur Neurol 2008; 59 Suppl 1: 17-26.
58. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473-483.
59. Schlachetzki F, Holscher T, Koch HJ, et al. Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J Ultrasound Med 2002; 21: 419-429.
60. Jungehulsing GJ, Brunecker P, Nolte CH, et al. Diagnostic transcranial ultrasound perfusion-imaging at 2.5 MHz does not affect the blood-brain barrier. Ultrasound Med Biol 2008; 34: 147-150.
61. Eyding J, Krogias C, Wilkening W, Postert T. Detection of cerebral perfusion abnormalities in acute stroke using phase inversion harmonic imaging (PIHI): preliminary results. J Neurol Neurosurg Psychiatry 2004; 75: 926-929.
62. Meyer-Wiethe K, Cangur H, Schindler A, Koch C, Seidel G. Ultrasound perfusion imaging: determination of thresholds for the identification of critically disturbed perfusion in acute ischemic stroke--a pilot study. Ultrasound Med Biol 2007; 33: 851-856.
63. Meyer K, Wiesmann M, Albers T, Seidel G. Harmonic imaging in acute stroke: detection of a cerebral perfusion deficit with ultrasound and perfusion MRI. J Neuroimaging 2003; 13: 166-168.
64. Postert T, Federlein J, Weber S, Przuntek H, Buttner T. Second harmonic imaging In acute middle cerebral artery infarction. Preliminary results. Stroke 1999; 30: 1702-1706.
65. Schlachetzki F, Hoelscher T, Dorenbeck U, et al. Sonographic parenchymal and brain perfusion imaging: preliminary results in four patients following decompressive surgery for malignant middle cerebral artery infarct. Ultrasound Med Biol 2001; 27: 21-31.
66. Seidel G, Albers T, Meyer K, Wiesmann M. Perfusion harmonic imaging in acute middle cerebral artery infarction. Ultrasound Med Biol 2003; 29: 1245-1251.
67. Shiogai T, Takayasu N, Mizuno T, Nakagawa M, Furuhata H. Comparison of transcranial brain tissue perfusion images between ultraharmonic, second harmonic, and power harmonic imaging. Stroke 2004; 35: 687-693.
68. Stolz E, Allendorfer J, Jauss M, Traupe H, Kaps M. Sonographic harmonic grey scale imaging of brain perfusion: scope of a new method demonstrated in selected cases. Ultraschall Med 2002; 23: 320-324.
69. Niesen W, Marouf W, Weiller C, Hetzel A. Transcranial perfusion sonography preceding thrombolysis - perfusion deficit correlates with clinical as well as vascular status. Cerebrovasc Dis 2008; 25: 27.
70. Meairs S. Contrast-enhanced ultrasound perfusion imaging in acute stroke patients. Eur Neurol 2008; 59 Suppl 1:17-26. Epub;%2008 Mar 26.: 17-26.
71. Kern R, Diels A, Pettenpohl J, et al. Real-time ultrasound brain perfusion imaging with analysis of microbubble replenishment in acute MCA stroke. J Cereb Blood Flow Metab 2011.
72. Meairs S, Culp W. Microbubbles for thrombolysis of acute ischemic stroke. Cerebrovasc Dis 2009; 27 Suppl 2: 55-65.
73. Sobbe A, Stumpff U, Trubestein G, Figge H, Kozuschek W. [Thrombolysis by ultrasound (author's transl)]. Klin Wochenschr 1974; 52: 1117-1121.
74. Harpaz D, Chen X, Francis CW, Meltzer RS. Ultrasound accelerates urokinase-induced thrombolysis and reperfusion. Am Heart J 1994; 127: 1211-1219.
75. Rosenschein U, Gaul G, Erbel R, et al. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation 1999; 99: 26-29.
76. Luo H, Birnbaum Y, Fishbein MC, et al. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998; 89: 171-177.
77. Riggs PN, Francis CW, Bartos SR, Penney DP. Ultrasound enhancement of rabbit femoral artery thrombolysis. Cardiovasc Surg 1997; 5: 201-207.
78. Hamm CW, Steffen W, Terres W, et al. Intravascular therapeutic ultrasound thrombolysis in acute myocardial infarctions. Am J Cardiol 1997; 80: 200-204.
79. Rosenschein U, Roth A, Rassin T, Basan S, Laniado S, Miller HI. Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial). Results of the feasibility phase. Circulation 1997; 95: 1411-1416.
80. Yock PG, Fitzgerald PJ. Catheter-based ultrasound thrombolysis. Circulation 1997; 95: 1360-1362.
81. Daffertshofer M, Hennerici M. Ultrasound in the treatment of ischaemic stroke. Lancet Neurol 2003; 2: 283-290.
82. Daffertshofer M, Fatar M. Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur J Ultrasound 2002; 16: 121-130.
83. Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351: 2170-2178.
84. Eggers J, Koch B, Meyer K, Konig I, Seidel G. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion. Ann Neurol 2003; 53: 797-800.
85. Pfaffenberger S, Devcic-Kuhar B, Kollmann C, et al. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model. Stroke 2005; 36: 124-128.
86. Meairs S, Dempfle CE. In vitro models for assessing transcranial ultrasound-enhanced thrombolysis. Stroke 2005; 36: 929-930.
87. Baron C, Aubry JF, Tanter M, Meairs S, Fink M. Simulation of intracranial acoustic fields in clinical trials of sonothrombolysis. Ultrasound Med Biol 2009; 35: 1148-1158.
88. Daffertshofer M, Gass A, Ringleb P, et al. Transcranial Low- requency Ultrasound-Mediated Thrombolysis in Brain Ischemia: Increased Risk of Hemorrhage With Combined Ultrasound and Tissue Plasminogen Activator: Results of a Phase II Clinical Trial. Stroke 2005; 36: 1441-1146.
89. Daffertshofer M, Huang Z, Fatar M, et al. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke. Neurosci Lett 2004; 361: 115-119.
90. Reinhard M, Hetzel A, Kruger S, et al. Blood-brain barrier disruption by low-frequency ultrasound. Stroke 2006; 37: 1546-1548.
91. Wang Z, Moehring MA, Voie AH, Furuhata H. In vitro evaluation of dual mode ultrasonic thrombolysis method for transcranial application with an occlusive thrombosis model. Ultrasound Med Biol 2008; 34: 96-102.
92. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995; 92: 1148-1150.
93. Porter TR, LeVeen RF, Fox R, Kricsfeld A, Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am Heart J 1996; 132: 964-968.
94. Cintas P, Nguyen F, Boneu B, Larrue V. Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles. J Thromb Haemost 2004; 2: 1163-1166.
95. Birnbaum Y, Luo H, Nagai T, et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998; 97: 130-134.
96. Tsivgoulis G, Alexandrov AV. Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety. Neurotherapeutics 2007; 4: 420-427.
97. Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol 2000; 26: 1153-1160.
98. Datta S, Coussios CC, Ammi AY, Mast TD, De Court, Holland CK. Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent. Ultrasound Med Biol 2008; 34: 1421-1433.
99. Miller MW, Miller DL, Brayman AA. A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. Ultrasound Med Biol 1996; 22: 1131-1154.
100. Datta S, Coussios CC, McAdory LE, et al. Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound Med Biol 2006; 32: 1257-1267.
101. Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006; 37: 425-429.
102. Perren F, Loulidi J, Poglia D, Landis T, Sztajzel R. Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke. J Thromb Thrombolysis 2008; 25: 219-223.
103. Pagola J, Ribo M, Alvarez-Sabin J, Lange M, Rubiera M, Molina CA. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Stroke 2007; 38: 2931-2934.
104. Porter TR, Kricsfeld D, Lof J, Everbach EC, Xie F. Effectiveness of transcranial and transthoracic ultrasound and microbubbles in dissolving intravascular thrombi. J Ultrasound Med 2001; 20: 1313-1325.
105. Culp WC, Porter TR, Xie F, et al. Microbubble potentiated ultrasound as a method of declotting thrombosed dialysis grafts: experimental study in dogs. Cardiovasc Intervent Radiol 2001; 24: 407-412.
106. Culp WC, Porter TR, McCowan TC, et al. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol 2003; 14: 343-347.
107. Culp WC, Erdem E, Roberson PK, Husain MM. Microbubble potentiated ultrasound as a method of stroke therapy in a pig model: preliminary findings. J Vasc Interv Radiol 2003; 14: 1433-1436.
108. Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial Clot Lysis With Intravenous Microbubbles and Transcranial Ultrasound in Swine. Stroke 2004; 35: 2407-2411.
109. Xie F, Tsutsui JM, Lof J, et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol 2005; 31: 979-985.
110. Alonso A, Della Martina A, Stroick M, et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 2007; 38: 1508-1514.
111. Alonso A, Dempfle CE, Della MA, et al. In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. Thromb Res 2009; 124: 70-74.
112. Fatar M, Stroick M, Griebe M, et al. Effect of combined ultrasound and microbubbles treatment in an experimental model of cerebral ischemia. Ultrasound Med Biol 2008; 34: 1414-1420.
113. Stroick M, Alonso A, Fatar M, et al. Effects of simultaneous application of ultrasound and microbubbles on intracerebral hemorrhage in an animal model. Ultrasound Med Biol 2006; 32: 1377-1382.
114. Dayton PA, Ferrara KW. Targeted imaging using ultrasound. J Magn Reson Imaging 2002; 16: 362-377.
115. Leong-Poi H, Christiansen J, Klibanov AL, Kaul S, Lindner JR. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation 2003; 107: 455-460.
116. Weller GE, Villanueva FS, Klibanov AL, Wagner WR. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng 2002; 30: 1012-1019.
117. Schumann PA, Christiansen JP, Quigley RM, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 2002; 37: 587-593.
118. Tardy I, Pochon S, Theraulaz M, Nanjappan P, Schneider M. In vivo ultrasound imaging of thrombi using a target-specific contrast agent. Acad Radiol 2002; 9 Suppl 2: S294-S296.
119. Christiansen JP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation 2002; 105: 1764-1767.
120. Lindner JR. Detection of inflamed plaques with contrast ultrasound. Am J Cardiol 2002; 90: 32L-35L.
121. Behm CZ, Kaufmann BA, Carr C, et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008; 117: 2902-2911.
122. Kaufmann BA, Carr CL, Belcik JT, et al. Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol 2010; 30: 54-59.
123. Piedra M, Allroggen A, Lindner JR. Molecular imaging with targeted contrast ultrasound. Cerebrovasc Dis 2009; 27 Suppl 2: 66-74.
124. Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-1239.
125. Ogawa K, Tachibana K, Uchida T, et al. High-resolution scanning electron microscopic evaluation of cell-membrane porosity by ultrasound. Med Electron Microsc 2001; 34: 249-253.
126. Mesiwala AH, Farrell L, Wenzel HJ, et al. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med Biol 2002; 28: 389-400.
127. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001; 220: 640-646.
128. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006; 340: 1085-1090.
129. McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 2006; 51: 793-807.
130. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 2005; 31: 1527-1537.
131. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007; 121: 901-907.
132. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004; 30: 979-989.
133. Sheikov N, McDannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 2008; 34: 1093-1104.
134. Alonso A, Reinz E, Jenne JW, et al. Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J Cereb Blood Flow Metab 2010.
135. Alonso A, Reinz E, Fatar M, Jenne J, Hennerici MG, Meairs S. Neurons but not glial cells overexpress ubiquitin in the rat brain following focused ultrasound-induced opening of the blood-brain barrier. Neuroscience 2010.
136. Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001; 44: 45-54.
137. Unger EC, McCreery TP, Sweitzer RH. Ultrasound enhances gene expression of liposomal transfection. Invest Radiol 1997; 32: 723-727.
138. Fischer AJ, Stanke JJ, Omar G, Askwith CC, Burry RW. Ultrasound-mediated gene transfer into neuronal cells. J Biotechnol 2006; 122: 393-411.
139. Fujii H, Sun Z, Li SH, et al. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc Imaging 2009; 2: 869-879.
140. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554-2556.
141. Nguyen PD, O'Rear EA, Johnson AE, Lu R, Fung BM. Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study. Proc Soc Exp Biol Med 1989; 192: 261-269.
142. Heeremans JL, Prevost R, Bekkers ME, et al. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost 1995; 73: 488-494.
143. Perkins WR, Vaughan DE, Plavin SR, et al. Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model. Thromb Haemost 1997; 77: 1174-1178.
144. Leach JK, O'Rear EA, Patterson E, Miao Y, Johnson AE. Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase. Thromb Haemost 2003; 90: 64-70.
145. Wang SS, Chou NK, Chung TW. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: An in vitro thrombolysis study. J Biomed Mater Res A 2008.
146. Xi X, Yang F, Chen D, et al. A targeting drug-delivery model via interactions among cells and liposomes under ultrasonic excitation. Phys Med Biol 2008; 53: 3251-3265.
147. Vandenbroucke RE, Lentacker I, Demeester J, De Smedt SC, Sanders NN. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control Release 2008; 126: 265-273.
148. Geers B, Lentacker I, Sanders NN, Demeester J, Meairs S, De Smedt SC. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. J Control Release 2011.
149. Marsh JN, Senpan A, Hu G, et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed 2007; 2: 533-543.